Skip to content
sellWeak cluster of 210b5-1 plan

Andrew Toy sold $1.3M of CLOV

Chief Executive Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE. 318,806 shares at an average of $4.19, traded Oct 1, 2026, filed Oct 2, 2026.

Warning score
38
Value
$1.3M
318,806 shares
Holdings after
9,140,510
-3% from before
From 52-week low
+149%
low $1.70, close $4.23
From 52-week high
-22%
high $5.41, as of Oct 1, 2026

Score components

  • Role
    CEO
    +25
  • Trade size
    $1.3M at market
    +25
  • Share of holdings sold
    Sold 3.4% of holdings
    0
  • Cluster
    2 insiders selling within 14 days
    +8
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CLOVOct 9, 2026 · close 4.79
Since filing Oct 2, 2026: +9.4%SPY +1.2% · excess +8.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001801170-26-000242, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026SOpen-market sale
Class A Common Stock10b5-1
-318,806$4.19$1.3M9,140,51011 d ago

Related signals

Other insiders at CLOVER HEALTH INVESTMENTS, CORP. /DE and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
13Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$9,288
2,006 shares
-0%
19Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$39k
8,750 shares
-0%
20Weak
CLOVsell 510b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$8,760
1,921 shares
-0%
10Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Frank Oldakowski
VP OF FINANCE AND CONTROLLER
$15k
3,170 shares
-1%
50Moderate
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Conrad Wai
CEO, Counterpart Health
$1.4M
300,000 shares
-20%
26Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$44k
9,273 shares
-0%
16Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Karen Soares
Chief Legal Officer
$33k
6,846 shares
-0%
40Moderate
CLOVsell 4
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Frank Oldakowski
VP OF FINANCE AND CONTROLLER
$103k
20,000 shares
-7%
20Weak
CLOVsell 310b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$11k
2,360 shares
-0%
17Weak
CLOVsell 310b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Frank Oldakowski
VP OF FINANCE AND CONTROLLER
$59k
12,102 shares
-4%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Andrew Toy sold $1.3M of CLOV | InsiderTell